In older patients, how does slower disease progression and shorter life expectancy typically influence vision loss?

• A. Variable
• B. Less Significant
• C. More Significant
• D. Unchanged

Answer: (B)

The amount of vision lost over a person’s lifetime depends on how quickly glaucoma progresses and how long they are expected to live. When the disease progresses slowly, the rate at which visual field and retinal nerve fiber loss occur is reduced. If life expectancy is shorter, there’s less time for that slow loss to accumulate. Together, these factors mean the total, lifetime impact on vision tends to be smaller for older patients, so the overall significance of vision loss is reduced. That’s why the best choice is that vision loss is less significant in this scenario. The other options don’t fit because they imply more, unpredictable, or unchanged impact, which doesn’t align with slower progression combined with a shorter remaining lifespan.